13 studies were found.

1.		Completed	A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3 Condition: HIV Infections
2.		Completed	A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination with Zidovudine (ZDV) versus ZDV alone in HIV-1 Infected Individuals with CD4 Counts of 200-500mm3 Condition: HIV Infections
3.		Recruiting	Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer Condition: Breast Cancer
4.		Completed	Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E Condition: HIV Infections
5.		Terminated	The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success with Protease Inhibitors Condition: HIV Infections
6.		Completed	Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients Condition: HIV Infections
7.		Completed	The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine Condition: HIV Infections
8.		Completed	Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals Condition: HIV Infections
9.		Completed	A Study of Delavirdine Mesylate in Combination with Other Anti-HIV Drugs in HIV-Infected Children and Babies Condition: HIV Infections
10.		Completed	A Study of Delavirdine Used Together with Other Anti-HIV Drugs in HIV-Infected Patients Condition: HIV Infections
11.		Completed	A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients Condition: HIV Infections
12.		Completed	A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients Condition: HIV Infections
13.		Completed	A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients Condition: HIV Infections